An isolated limb infusion technique: A guide for the perfusionist

Journal of Extra-Corporeal Technology

Volumn 37, Issue 4, 2005, Pages 396-399

  McDermott, Patricia ^a   Lawson, D Scott ^a   Walczak, Richard ^a   Tyler, Douglas ^a   Shearer, Ian R ^a  

^a DUKE UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

Chemotherapy; Hyperthermic isolated limb perfusion; Isolated limb infusion; Melanoma; Melphalan

Indexed keywords

CYTOTOXIC AGENT; DACTINOMYCIN; MELPHALAN; ALKYLATING AGENT;

ACIDOSIS; ANGIOGRAPHY; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; BLOOD VESSEL INJURY; CANNULATION; CARDIOPLEGIA; CATHETERIZATION; ECONOMIC ASPECT; HEAT EXCHANGE; HUMAN; HYPERTHERMIA; HYPOXIA; INFECTION; LIMB PERFUSION; MELANOMA; MORBIDITY; OUTCOME ASSESSMENT; SURGICAL TECHNIQUE; TECHNIQUE; HEART ARREST; HYPERTHERMIC THERAPY; INSTRUMENTATION; LIMB; METHODOLOGY; PERFUSION;

ANTINEOPLASTIC AGENTS, ALKYLATING; EXTREMITIES; HEART ARREST, INDUCED; HUMANS; HYPERTHERMIA, INDUCED; MELANOMA; MELPHALAN; PERFUSION;

EID: 33645944668     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Thompson JF, Waugh RC, Saw RM, Kam P. Isolated limb infusion with melphalan for recurrent limb melanoma: a simple alternative to isolated limb perfusion. Reg Cancer Treat. 1994;7:188-92.
2. Thompson JF, Kam PC, Waugh RC, Harman R. Isolated limb infusion with cytotoxic agents: A simple alternative to isolated limb perfusion. Semin Surg Oncol. 1998;14:238-47.
3. Thompson JF, Lai DM, Ingvar C, Kam PC. Maximizing efficacy and minimizing toxicity in isolated limb perfusion for melanoma. Melanoma Res. 1994;4(Suppl 1):45-50.
4. Thompson JF, deWilt JF. Isolated limb perfusion in the management of patients with recurrent limb melanoma: an important but limited role. Ann Surg Oncol. 2001;8:564-5.
5. Thompson JF, Hunt JA, Shannon KF, Kam PC. Frequency and duration of remission after isolated limb perfusion for melanoma. Arch Surg. 1997;132:903-7.
6. Lindnèr P, Doubrovsky A, Kam PC, Thompson JF. Prognostic factors after isolated limb infusion with cytotoxic agents for melanoma. Ann Surg Oncol. 2002;9:127-36.
7. Siemann DW, Chapman M, Beikirch A. Effects of oxygenation and pH on tumor cell response to alkylating chemotherapy. Int J Radiat Oncol Biol Phys. 1991;20:287-9.
8. Skarsgard LD, Skwarchuk MV, Vinczan A, Kristl J, Chaplin DJ. The cytotoxicity of melphalan and its relationship to pH, hypoxia, and drug uptake. Anticancer Res. 1995;15:219-23.
9. Cavaliere R, Ciocatto RC, Giovanella BC, et al. Selective heat sensitivity of cancer cells: Biochemical and clinical studies. Cancer. 20: 1351-81.
10. Kroon BR. Regional isolation perfusion in melanoma of the limbs: Accomplishments, unsolved problems, future. Eur J Surg Oncol. 1998;14:101-10.